Voice disorders
Therapeutic area
Pulmonology
Rare disease
No
- Definition
- A pathologic process in the larynx that affects the production of speech. Causes include vocal cord paresis, vocal cord nodule, vocal cord polyp, and laryngitis.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Voice disorders
- Therapeutic area
- Pulmonology
- voice disorders
- neurologic voice disorder
- voice disorder
- All therapeutic areas
- Pulmonology
- Severity
- Mild
- MONDO ID
- MONDO:0043862
- Parent condition
- MONDO:0004382
Related records
Broader conditions (6)
- Disease
- Disease by body system or component
- Human disease
- Laryngeal disorder
- Respiratory system disorder
- Upper respiratory tract disorder
Trials (440)
- "Effects of EMST and Triflo on Voice Parameters and Vocal Fatigue"
- 3D Thyroid Education Model for Student
- 90-Day Cobalt Supplementation Study to Investigate the Cobalt Body Burden in Ten Healthy Adult Volunteers
- 99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients
- A Deep Learning Method to Predict Difficult Laryngoscopy Using Cervical Spine X-ray Image
- A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors
- A Gene Hunting Study for Familial Papillary Thyroid Cancer
- A Novel Technique for Endoscopic Transaxillary Thyroidectomy Comparison
- A Novel Ultrasound Probe for Thyroid Imaging and Machine Learning
- A Nutritarian Study to Evaluate the Effectiveness of Lifestyle Changes in Chronic Disease Prevention, Especially Cancer
- A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
- A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients
- A Prospective Evaluation of Radiofrequency Ablation in the Treatment of Relapsed Graves' Disease.
- A Prospective, Single-arm, Multi-centre, Blinded, Observational, Diagnostic Accuracy Study With a Diagnostic Medical Product
- A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
- A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
- A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants
- A Study of KL590586 in Patients With Advanced Solid Tumors
- A Study of Online Follow-up in Patients With Papillary Thyroid Cancer
- A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
Drugs in development (3)
- Caffeine Early phase 1
- Dextromethorphan Phase 1
- Lorazepam Phase 1
Other linked drugs (1)
- Betamethasone